BioAffinity Technologies, Subsidiary Oncoselect Therapeutics, Has Been Granted U.S. Patent Number 11,590,233 Titled "Porphyrin Compounds And Compositions Useful For Treating Cancer"
BioAffinity Technologies, Subsidiary Oncoselect Therapeutics, Has Been Granted U.S. Patent Number 11,590,233 Titled "Porphyrin Compounds And Compositions Useful For Treating Cancer"
BioAffinity Technologies,子公司 Oncoselect Therapeutics已获得美国专利号 11,590,233，标题为 “可用于治疗癌症的卟啉化合物和组合物”
BioAffinity Technologies,子公司 Oncoselect Therapeutics已获得美国专利号 11,590,233，标题为 “可用于治疗癌症的卟啉化合物和组合物”
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。